Catalyst Biosciences Inc (CBIO)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Catalyst Biosciences Inc (CBIO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011541
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Catalyst Biosciences Inc (Catalyst), formerly Targacept Inc is a clinical-stage biopharmaceutical company that develops novel medicines to address hematology indications. The company discovers and develops next generation biopharmaceuticals based on engineered human proteases platform technology. It concentrates on the development of products for hemostasis and anti-complement. Catalyst’s hemostasis product portfolio includes FVlla, FIX, and FXa; and anti-complement product portfolio comprises anti-C3, anti-C3, and anti-FB. The company’s products find application in the treatment of diseases such as hemophilia, macular degeneration, inflammation, myocardial ischemia, coronary artery bypass grafting and stroke. It operates through various international pharmaceutical companies to develop and commercialize its engineered human proteases. Catalyst is headquartered in South San Francisco, California, the US.

Catalyst Biosciences Inc (CBIO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Catalyst Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Catalyst Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Catalyst Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Catalyst Biosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Catalyst Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Catalyst Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Catalyst Biosciences Raises Additional USD0.89 Million in Financing 10
Catalyst Biosciences Raises USD3.2 Million in Venture Financing 11
Catalyst Biosciences Raises US$5 Million In Venture Financing 12
Equity Offering 13
Catalyst Biosciences to Raise Funds through Public Offering of Shares 13
Catalyst Biosciences Raises USD20.7 Million in Public Offering of Units 14
Catalyst Biosciences Raises USD6.5 million in Public Offering of Shares 15
Debt Offering 16
Catalyst Biosciences Raises USD37 Million in Private Placement of Notes 16
Catalyst Biosciences Inc – Key Competitors 17
Catalyst Biosciences Inc – Key Employees 18
Catalyst Biosciences Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
Nov 02, 2017: Catalyst Biosciences Reports Third Quarter 2017 Operating & Financial Results and Provides Corporate Update 20
May 11, 2017: Catalyst Biosciences Reports First Quarter 2017 Financial Results and Provides Corporate Update 21
Mar 08, 2017: Catalyst Biosciences Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 22
Nov 03, 2016: Catalyst Biosciences Reports Third Quarter 2016 Financial Results and Provides Corporate Update 23
Aug 04, 2016: Catalyst Biosciences Reports Second Quarter 2016 Financial Results and Provides Corporate Update 24
Corporate Communications 25
Dec 14, 2017: Catalyst Biosciences Announces Appointment of Edward Williams to its Board of Directors 25
Nov 28, 2017: Catalyst Biosciences Strengthens Clinical Hemophilia Programs with Additions to its Senior Leadership Team 26
Feb 16, 2017: Catalyst Biosciences Announces Promotion of Andrew Hetherington to SVP of Technical Operations 27
Apr 18, 2016: Catalyst Biosciences Announces Appointments of Chief Medical Officer and Vice President of Business Development 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Catalyst Biosciences Inc, Medical Equipment, Key Facts, 2016 2
Catalyst Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Catalyst Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Catalyst Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Catalyst Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Catalyst Biosciences Inc, Deals By Market, 2011 to YTD 2017 8
Catalyst Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Catalyst Biosciences Raises Additional USD0.89 Million in Financing 10
Catalyst Biosciences Raises USD3.2 Million in Venture Financing 11
Catalyst Biosciences Raises US$5 Million In Venture Financing 12
Catalyst Biosciences to Raise Funds through Public Offering of Shares 13
Catalyst Biosciences Raises USD20.7 Million in Public Offering of Units 14
Catalyst Biosciences Raises USD6.5 million in Public Offering of Shares 15
Catalyst Biosciences Raises USD37 Million in Private Placement of Notes 16
Catalyst Biosciences Inc, Key Competitors 17
Catalyst Biosciences Inc, Key Employees 18

★調査レポート[Catalyst Biosciences Inc (CBIO)-医療機器分野:企業M&A・提携分析] (コード:DATA8011541)販売に関する免責事項を必ずご確認ください。
★調査レポート[Catalyst Biosciences Inc (CBIO)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆